Project Scleroderma

Analysis

Project Scleroderma is a registered charity in United States, based in Havertown, PA. It received its IRS tax-exemption ruling in January 2015, 11 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Project Scleroderma reported income of $112k and spending of $104k, spending 94% of its income. Across the 2 years on record, from December 2022 to December 2023, income grew from $30k to $112k (+269%), an average of +269% a year. The sharpest change came in the year to December 2023, when income rose by 269%. Over the whole period it spent 93% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Project Scleroderma sits at the 30th percentile: it is larger than about 30% of them. Against every charity in United States with reported income it ranks in the 40th percentile, and in the 38th percentile within PA. Charities of a similar size with the same main cause include Anterior Cruciate Ligament Study Group ($112k), Recovering Communities of Step Ahead ($112k) and Lupita Project ($112k).

On its Form 990-EZ for the period ending December 2023, revenue came from contributions and grants 100% of the total. At year end it held assets of $22k against liabilities of $0, net assets of $22k.